thymopentin has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun-Falco, O; Burg, G; Przybilla, B; Schmoeckel, C | 1 |
| Claudy, A; Faure, M; Mauduit, G; Nicolas, JF; Thivolet, J | 1 |
2 trial(s) available for thymopentin and Lymphoma
| Article | Year |
|---|---|
Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hormones; Humans; Lymphoma; Male; Middle Aged; Mycosis Fungoides; Peptide Fragments; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1983 |
Therapeutic use of TP5 (thymopoietin 32-36) in sarcoidosis of the skin.
Topics: Adult; Antibody Formation; Autoantibodies; Clinical Trials as Topic; Erythema Nodosum; Female; Humans; Immunity, Cellular; Immunoglobulin E; Lung Neoplasms; Lymphoma; Male; Peptide Fragments; Sarcoidosis; Skin Diseases; Syndrome; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1983 |